355 related articles for article (PubMed ID: 9823898)
1. The murine gene p27Kip1 is haplo-insufficient for tumour suppression.
Fero ML; Randel E; Gurley KE; Roberts JM; Kemp CJ
Nature; 1998 Nov; 396(6707):177-80. PubMed ID: 9823898
[TBL] [Abstract][Full Text] [Related]
2. Tumor suppression by p27Kip1 and p21Cip1 during chemically induced skin carcinogenesis.
Philipp J; Vo K; Gurley KE; Seidel K; Kemp CJ
Oncogene; 1999 Aug; 18(33):4689-98. PubMed ID: 10467416
[TBL] [Abstract][Full Text] [Related]
3. Mutation and expression analysis of the p27/kip1 gene in corticotrophin-secreting tumours.
Dahia PL; Aguiar RC; Honegger J; Fahlbush R; Jordan S; Lowe DG; Lu X; Clayton RN; Besser GM; Grossman AB
Oncogene; 1998 Jan; 16(1):69-76. PubMed ID: 9467944
[TBL] [Abstract][Full Text] [Related]
4. p27(Kip1): regulation and function of a haploinsufficient tumor suppressor and its misregulation in cancer.
Philipp-Staheli J; Payne SR; Kemp CJ
Exp Cell Res; 2001 Mar; 264(1):148-68. PubMed ID: 11237531
[TBL] [Abstract][Full Text] [Related]
5. p27Kip1-deficient mice exhibit accelerated growth hormone-releasing hormone (GHRH)-induced somatotrope proliferation and adenoma formation.
Teixeira LT; Kiyokawa H; Peng XD; Christov KT; Frohman LA; Kineman RD
Oncogene; 2000 Apr; 19(15):1875-84. PubMed ID: 10773877
[TBL] [Abstract][Full Text] [Related]
6. [P27Kip1 is certainly a suppressor gene but with a dose effect].
Jeanteur P
Bull Cancer; 1998 Dec; 85(12):990. PubMed ID: 9988555
[No Abstract] [Full Text] [Related]
7. Loss of the cell cycle inhibitors p21(Cip1) and p27(Kip1) enhances tumorigenesis in knockout mouse models.
Jackson RJ; Adnane J; Coppola D; Cantor A; Sebti SM; Pledger WJ
Oncogene; 2002 Dec; 21(55):8486-97. PubMed ID: 12466968
[TBL] [Abstract][Full Text] [Related]
8. The ubiquitous transcription factor NF-Y positively regulates the transcription of human p27Kip1 through a CCAAT box located in the 5-upstream region of the p27Kip1 gene.
Kamiyama J; Inoue T; Ohtani-Fujita N; Minami S; Yamagishi H; Sakai T
FEBS Lett; 1999 Jul; 455(3):281-5. PubMed ID: 10437789
[TBL] [Abstract][Full Text] [Related]
9. p27/Kip1 mutation found in breast cancer.
Spirin KS; Simpson JF; Takeuchi S; Kawamata N; Miller CW; Koeffler HP
Cancer Res; 1996 May; 56(10):2400-4. PubMed ID: 8625318
[TBL] [Abstract][Full Text] [Related]
10. Accommodating haploinsufficient tumor suppressor genes in Knudson's model.
Cook WD; McCaw BJ
Oncogene; 2000 Jul; 19(30):3434-8. PubMed ID: 10918600
[No Abstract] [Full Text] [Related]
11. Pten and p27KIP1 cooperate in prostate cancer tumor suppression in the mouse.
Di Cristofano A; De Acetis M; Koff A; Cordon-Cardo C; Pandolfi PP
Nat Genet; 2001 Feb; 27(2):222-4. PubMed ID: 11175795
[TBL] [Abstract][Full Text] [Related]
12. The cell cycle regulator p27kip1 contributes to growth and differentiation of osteoblasts.
Drissi H; Hushka D; Aslam F; Nguyen Q; Buffone E; Koff A; van Wijnen A; Lian JB; Stein JL; Stein GS
Cancer Res; 1999 Aug; 59(15):3705-11. PubMed ID: 10446985
[TBL] [Abstract][Full Text] [Related]
13. Deficiency in the gap junction protein connexin32 alters p27Kip1 tumor suppression and MAPK activation in a tissue-specific manner.
King TJ; Gurley KE; Prunty J; Shin JL; Kemp CJ; Lampe PD
Oncogene; 2005 Mar; 24(10):1718-26. PubMed ID: 15608667
[TBL] [Abstract][Full Text] [Related]
14. Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in human malignancies.
Kawamata N; Morosetti R; Miller CW; Park D; Spirin KS; Nakamaki T; Takeuchi S; Hatta Y; Simpson J; Wilcyznski S
Cancer Res; 1995 Jun; 55(11):2266-9. PubMed ID: 7757974
[TBL] [Abstract][Full Text] [Related]
15. Distinct roles for p53, p27Kip1, and p21Cip1 during tumor development.
Philipp-Staheli J; Kim KH; Liggitt D; Gurley KE; Longton G; Kemp CJ
Oncogene; 2004 Jan; 23(4):905-13. PubMed ID: 14647411
[TBL] [Abstract][Full Text] [Related]
16. TGF-beta 1 induces the cyclin-dependent kinase inhibitor p27Kip1 mRNA and protein in murine B cells.
Kamesaki H; Nishizawa K; Michaud GY; Cossman J; Kiyono T
J Immunol; 1998 Jan; 160(2):770-7. PubMed ID: 9551912
[TBL] [Abstract][Full Text] [Related]
17. Cell cycle regulators in bladder cancer: a multivariate survival study with emphasis on p27Kip1.
Korkolopoulou P; Christodoulou P; Konstantinidou AE; Thomas-Tsagli E; Kapralos P; Davaris P
Hum Pathol; 2000 Jun; 31(6):751-60. PubMed ID: 10872671
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the effectiveness of adenovirus vectors expressing cyclin kinase inhibitors p16INK4A, p18INK4C, p19INK4D, p21(WAF1/CIP1) and p27KIP1 in inducing cell cycle arrest, apoptosis and inhibition of tumorigenicity.
Schreiber M; Muller WJ; Singh G; Graham FL
Oncogene; 1999 Mar; 18(9):1663-76. PubMed ID: 10208428
[TBL] [Abstract][Full Text] [Related]
19. p27 Expression, a cyclin dependent kinase inhibitor in breast carcinoma.
Barbareschi M
Adv Clin Path; 1999 Oct; 3(4):119-27. PubMed ID: 10936889
[TBL] [Abstract][Full Text] [Related]
20. PTEN expression is reduced in a subset of sporadic thyroid carcinomas: evidence that PTEN-growth suppressing activity in thyroid cancer cells mediated by p27kip1.
Bruni P; Boccia A; Baldassarre G; Trapasso F; Santoro M; Chiappetta G; Fusco A; Viglietto G
Oncogene; 2000 Jun; 19(28):3146-55. PubMed ID: 10918569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
